Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...

The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.

Dec 12 (Reuters) - Novo Nordisk said on Friday the European Medicines Agency's committee had issued a positive opinion for a ...

Dec 12 (Reuters) - The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's ...

Dec 12 (Reuters) - GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory ...

LEO Pharma has submitted a label expansion application to EMA to expand Anzupgo® (delgocitinib) cream to adolescent patients ...

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability ...

Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication: Berlin Monday, December 15, 2025, 13:00 Hrs [IST] The Committee for Medicinal Products ...

Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd , has entered into two strategic agreements with privately held Hasten ...

Shares of ImmunityBio ticked higher after the company said the European Medicines Agency recommended granting a conditional marketing authorization for its treatment for non-muscle invasive bladder ...

This recall affects America’s most prescribed drug. It’s the latest in a series of concerning manufacturing issues that have ...

EMA recommends conditional authorization for ImmunityBio's Anktiva with BCG after a 71% complete response rate in ...